Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
allogeneic plx-pad cells (1 trial)
s-equol (1 trial)
Hyperplasia (Phase 2)
Intermittent Claudication (Phase 2)
Peripheral Arterial Disease (Phase 2)
Prostatic Hyperplasia (Phase 2)
Trials (2 total)
Trial APIs (2 total)